title: Management of Brugada Syndrome 2016: Should All High Risk Patients Receive an ICD? All High-Risk Patients Should Receive an Implantable Cardiac Defibrillator.
authors.affiliation: From the Heart Rhythm Management Centre, UZ Brussel-VUB, Brussels, Belgium.
authors.forename: Juan
authors.initials: J
authors.lastname: Sieira
authors.affiliation: From the Heart Rhythm Management Centre, UZ Brussel-VUB, Brussels, Belgium. pedro@brugada.org.
authors.forename: Pedro
authors.initials: P
authors.lastname: Brugada
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D053840:Brugada Syndrome / Q000503:physiopathology / Q000628:therapy*; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D004562:Electrocardiography; D022062:Electrophysiologic Techniques, Cardiac; D006801:Humans; D018579:Patient Selection; D010641:Phenotype; D011802:Quinidine / Q000627:therapeutic use
chemical_list: D000889:Anti-Arrhythmia Agents; D011802:Quinidine
keywords: Brugada syndrome; implanted cardioverter defibrillator; right ventricle; sudden cardiac death; ventricular fibrillation